MEDIORG

Medicamen Organics Share Price

 

 

Start SIP in MEDIORG

Start SIP

Performance

  • Low
  • ₹27
  • High
  • ₹30
  • 52 Week Low
  • ₹20
  • 52 Week High
  • ₹50
  • Open Price₹29
  • Previous Close₹29
  • Volume42,000
  • 50 DMA₹26.46
  • 100 DMA₹29.12
  • 200 DMA₹35.73

Investment Returns

  • Over 1 Month + 14.85%
  • Over 3 Month -5.18%
  • Over 6 Month -19.5%
  • Over 1 Year -27.67%

Smart Investing Starts Here Start SIP with Medicamen Organics for Steady Growth!

Invest Now

Medicamen Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 8.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 33
  • P/B Ratio
  • 1
  • Average True Range
  • 1.26
  • EPS
  • 3.46
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.18
  • RSI
  • 56.55
  • MFI
  • 78.77

Medicamen Organics Financials

Medicamen Organics Technicals

EMA & SMA

Current Price
₹27.45
-1.4 (-4.85%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹25.83
  • 50 Day
  • ₹26.46
  • 100 Day
  • ₹29.12
  • 200 Day
  • ₹35.73

Resistance and Support

28.38 Pivot Speed
  • R3 32.12
  • R2 31.18
  • R1 29.32
  • S1 26.52
  • S2 25.58
  • S3 23.72

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Medicamen Organics Ltd has an operating revenue of Rs. 81.31 Cr. on a trailing 12-month basis. An annual revenue growth of 51% is outstanding, Pre-tax margin of 14% is healthy, ROE of 13% is good. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 45 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 131 indicates it belongs to a poor industry group of Medical-Products and a Master Score of D is close to being the worst. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Medicamen Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-05-29 Audited Results
2025-01-08 To consider Fund Raising
2024-11-14 Quarterly Results & Others To consider other business matters.

Medicamen Organics F&O

Medicamen Organics Shareholding Pattern

59.73%
30.58%
9.69%

About Medicamen Organics

  • NSE Symbol
  • MEDIORG
  • BSE Symbol
  • Chairman & Managing Director
  • Mr. Bal Kishan Gupta
  • ISIN
  • INE0PE401018

Similar Stocks to Medicamen Organics

Medicamen Organics FAQs

Medicamen Organics share price is ₹27 As on 14 February, 2026 | 04:38

The Market Cap of Medicamen Organics is ₹33.4 Cr As on 14 February, 2026 | 04:38

The P/E ratio of Medicamen Organics is 8.3 As on 14 February, 2026 | 04:38

The PB ratio of Medicamen Organics is 1 As on 14 February, 2026 | 04:38

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23